Published in Mol Cell Biol on March 01, 2005
Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. Mol Cell (2007) 4.33
Mechanisms, regulation and consequences of protein SUMOylation. Biochem J (2010) 3.22
Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J Clin Invest (2007) 3.19
Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol Cell Biol (2005) 3.05
PDSM, a motif for phosphorylation-dependent SUMO modification. Proc Natl Acad Sci U S A (2005) 3.01
Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications. Mol Cell Biol (2005) 2.28
Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications. Genes Dev (2006) 2.15
Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol Cell Biol (2006) 2.01
Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes. Mol Cell Biol (2008) 1.89
SUMOsp: a web server for sumoylation site prediction. Nucleic Acids Res (2006) 1.88
An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J (2006) 1.86
Mechanisms underlying the transcriptional regulation of skeletal myogenesis. Curr Opin Genet Dev (2005) 1.82
An expression screen reveals modulators of class II histone deacetylase phosphorylation. Proc Natl Acad Sci U S A (2005) 1.71
An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol Cell Biol (2007) 1.69
mef2ca is required in cranial neural crest to effect Endothelin1 signaling in zebrafish. Dev Biol (2007) 1.30
Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation. Mol Cell Biol (2008) 1.23
Protein kinase A represses skeletal myogenesis by targeting myocyte enhancer factor 2D. Mol Cell Biol (2008) 1.18
Histone deacetylase 7 and FoxA1 in estrogen-mediated repression of RPRM. Mol Cell Biol (2009) 1.15
ZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein-Barr virus infection in gastric AGS cells. J Virol (2007) 1.14
Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues. Exp Cell Res (2006) 1.13
Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity. BMC Biochem (2006) 1.10
Regulation of the sumoylation system in gene expression. Curr Opin Cell Biol (2008) 1.09
Sumoylation and regulation of cardiac gene expression. Circ Res (2010) 1.08
Beyond histone and deacetylase: an overview of cytoplasmic histone deacetylases and their nonhistone substrates. J Biomed Biotechnol (2010) 1.08
SUMO-1 modification of MEF2A regulates its transcriptional activity. J Cell Mol Med (2006) 1.06
Structure of p300 bound to MEF2 on DNA reveals a mechanism of enhanceosome assembly. Nucleic Acids Res (2011) 1.06
Effects of MEK5/ERK5 association on small ubiquitin-related modification of ERK5: implications for diabetic ventricular dysfunction after myocardial infarction. Circ Res (2008) 1.05
Distinct mechanisms involving diverse histone deacetylases repress expression of the two gonadotropin beta-subunit genes in immature gonadotropes, and their actions are overcome by gonadotropin-releasing hormone. Mol Cell Biol (2007) 1.05
Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation. Oncogene (2011) 1.05
Neuronal SUMOylation: mechanisms, physiology, and roles in neuronal dysfunction. Physiol Rev (2014) 1.02
Regulation of histone deacetylase 4 expression by the SP family of transcription factors. Mol Biol Cell (2005) 1.02
Human polycomb 2 protein is a SUMO E3 ligase and alleviates substrate-induced inhibition of cystathionine beta-synthase sumoylation. PLoS One (2008) 1.00
Dephosphorylation and caspase processing generate distinct nuclear pools of histone deacetylase 4. Mol Cell Biol (2007) 0.93
Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis. J Biol Chem (2008) 0.93
Viral manipulation of cellular protein conjugation pathways: The SUMO lesson. World J Virol (2013) 0.92
Sumoylation of LAP1 is involved in the HDAC4-mediated repression of COX-2 transcription. Nucleic Acids Res (2008) 0.92
HDAC4: mechanism of regulation and biological functions. Epigenomics (2014) 0.92
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma. Acta Neuropathol Commun (2015) 0.91
Unique functional roles for class I and class II histone deacetylases in central nervous system development and function. Int J Dev Neurosci (2013) 0.90
SUMOylation in control of accurate chromosome segregation during mitosis. Curr Protein Pept Sci (2012) 0.89
Sumoylated MEF2A coordinately eliminates orphan presynaptic sites and promotes maturation of presynaptic boutons. J Neurosci (2013) 0.89
SUMO--a post-translational modification with therapeutic potential? Curr Opin Pharmacol (2010) 0.89
HDAC2 promotes eIF4E sumoylation and activates mRNA translation gene specifically. J Biol Chem (2010) 0.88
The silencing of the SWI/SNF subunit and anticancer gene BRM in Rhabdoid tumors. Oncotarget (2014) 0.87
Subcellular localization of class II HDAs in Arabidopsis thaliana: nucleocytoplasmic shuttling of HDA15 is driven by light. PLoS One (2012) 0.87
Two tales concerning skeletal muscle. J Clin Invest (2007) 0.85
The Epstein-Barr virus LF2 protein inhibits viral replication. J Virol (2008) 0.85
DNA double-strand breaks lead to activation of hypermethylated in cancer 1 (HIC1) by SUMOylation to regulate DNA repair. J Biol Chem (2013) 0.85
Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics. Expert Opin Ther Targets (2013) 0.84
Mutually exclusive STAT1 modifications identified by Ubc9/substrate dimerization-dependent SUMOylation. Nucleic Acids Res (2009) 0.84
Class I and IIa histone deacetylases have opposite effects on sclerostin gene regulation. J Biol Chem (2014) 0.83
SUMO modification of Stra13 is required for repression of cyclin D1 expression and cellular growth arrest. PLoS One (2012) 0.83
SUMO modification regulates the transcriptional repressor function of aryl hydrocarbon receptor repressor. J Biol Chem (2009) 0.83
Strategies to Identify Recognition Signals and Targets of SUMOylation. Biochem Res Int (2012) 0.83
Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms. J Physiol (2014) 0.82
Sumoylation of the basic helix-loop-helix transcription factor sharp-1 regulates recruitment of the histone methyltransferase G9a and function in myogenesis. J Biol Chem (2013) 0.82
Histone deacetylase 7 (HDAC7) regulates myocyte migration and differentiation. Biochim Biophys Acta (2010) 0.82
Homeodomain-interacting protein kinase 2-dependent repression of myogenic differentiation is relieved by its caspase-mediated cleavage. Nucleic Acids Res (2013) 0.81
Multiple novel functions of lamina associated polypeptide 2α in striated muscle. Nucleus (2011) 0.80
Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern? Circ Res (2010) 0.79
Long-Term Memory in Drosophila Is Influenced by Histone Deacetylase HDAC4 Interacting with SUMO-Conjugating Enzyme Ubc9. Genetics (2016) 0.77
Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer. J Cancer Res Clin Oncol (2015) 0.76
Modulation of TonEBP activity by SUMO modification in response to hypertonicity. Front Physiol (2014) 0.76
Hepatocyte DACH1 Is Increased in Obesity via Nuclear Exclusion of HDAC4 and Promotes Hepatic Insulin Resistance. Cell Rep (2016) 0.76
Evidence for a non-canonical role of HDAC5 in regulation of the cardiac Ncx1 and Bnp genes. Nucleic Acids Res (2015) 0.76
Sumoylation in Synaptic Function and Dysfunction. Front Synaptic Neurosci (2016) 0.75
A class of their own: exploring the nondeacetylase roles of class IIa HDACs in cardiovascular disease. Am J Physiol Heart Circ Physiol (2016) 0.75
Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma. Oncotarget (2015) 0.75
Up-regulation of SUMO E3 ligases during lung schistosomula and adult worm stages. Parasitol Res (2014) 0.75
Reversal of pathological cardiac hypertrophy via the MEF2-coregulator interface. JCI Insight (2017) 0.75
Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev (2000) 9.36
Acetylation: a regulatory modification to rival phosphorylation? EMBO J (2000) 7.35
SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell (1998) 6.62
Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol (2004) 6.00
PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol (1999) 5.83
The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell (2002) 5.80
PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev (2001) 5.79
HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J (1999) 5.54
Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem (2001) 5.43
Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J (1998) 5.15
Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J Biol Chem (2001) 5.04
MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci (2002) 4.96
SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem (2000) 4.96
A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet (2004) 4.95
SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev (2004) 4.80
Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol (2003) 4.76
Binary switches and modification cassettes in histone biology and beyond. Nature (2003) 4.75
SUMO, ubiquitin's mysterious cousin. Nat Rev Mol Cell Biol (2001) 4.65
Class II histone deacetylases: versatile regulators. Trends Genet (2003) 4.63
Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature (1997) 4.59
BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J (1997) 4.51
Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol (2004) 4.49
Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell (2002) 4.09
The polycomb protein Pc2 is a SUMO E3. Cell (2003) 3.91
P300 transcriptional repression is mediated by SUMO modification. Mol Cell (2003) 3.67
Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chem Biol (2002) 3.66
Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell (1997) 3.54
Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science (2003) 3.34
Modification with SUMO. A role in transcriptional regulation. EMBO Rep (2003) 3.25
PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol Cell Biol (2002) 3.25
HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol Cell Biol (1999) 3.21
Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science (1999) 3.19
Histone deacetylases, transcriptional control, and cancer. J Cell Physiol (2000) 3.18
Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways. Mol Cell Biol (2001) 3.09
Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol (1999) 3.02
SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol Cell (2002) 2.93
SUMO: ligases, isopeptidases and nuclear pores. Trends Biochem Sci (2003) 2.92
Lysine acetylation and the bromodomain: a new partnership for signaling. Bioessays (2004) 2.84
Functional significance of histone deacetylase diversity. Curr Opin Genet Dev (2001) 2.79
Regulation of histone deacetylase 4 by binding of 14-3-3 proteins. Mol Cell Biol (2000) 2.69
The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J (2002) 2.56
Multisite protein modification and intramolecular signaling. Oncogene (2005) 2.42
Transcriptional regulation by histone ubiquitination and deubiquitination. Genes Dev (2003) 2.27
Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron (2003) 2.19
Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. Science (1999) 2.17
Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol Cell Biol (2003) 2.17
A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex. Structure (2004) 2.15
Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol Biol Cell (2004) 2.14
A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J Biol Chem (2004) 2.13
HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis. Immunity (2003) 2.10
ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain. Mol Cell Biol (2000) 2.02
Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression. Curr Opin Genet Dev (2003) 1.95
Regulatory role of MEF2D in serum induction of the c-jun promoter. Mol Cell Biol (1995) 1.93
A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy. Mol Cell Biol (2000) 1.90
Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes. Proc Natl Acad Sci U S A (2002) 1.89
SUMO and transcriptional regulation. Semin Cell Dev Biol (2004) 1.82
SUMO-1 protease-1 regulates gene transcription through PML. Mol Cell (2002) 1.80
A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase. Eur J Biochem (2000) 1.75
CaM-kinases: modulators of synaptic plasticity. Curr Opin Neurobiol (2000) 1.73
Histone deacetylase 4 possesses intrinsic nuclear import and export signals. Mol Cell Biol (2001) 1.68
Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1. Nucleic Acids Res (1998) 1.65
Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy. Proc Natl Acad Sci U S A (2003) 1.60
Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. J Biol Chem (2000) 1.57
Deconstructing PML-induced premature senescence. EMBO J (2002) 1.56
A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3. J Biol Chem (2003) 1.52
Caspase-dependent regulation of histone deacetylase 4 nuclear-cytoplasmic shuttling promotes apoptosis. Mol Biol Cell (2004) 1.51
Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A. J Biol Chem (2003) 1.44
Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology. Trends Cardiovasc Med (2000) 1.35
The histone deacetylase 9 gene encodes multiple protein isoforms. J Biol Chem (2003) 1.32
Epidermal growth factor induction of the c-jun promoter by a Rac pathway. Mol Cell Biol (1998) 1.30
Caspase-mediated specific cleavage of human histone deacetylase 4. J Biol Chem (2004) 1.29
Cytoplasmic sequestration of HDAC7 from mitochondrial and nuclear compartments upon initiation of apoptosis. J Biol Chem (2004) 1.29
Regulated SUMOylation and ubiquitination of DdMEK1 is required for proper chemotaxis. Dev Cell (2002) 1.26
Phosphorylation of the histone deacetylase 7 modulates its stability and association with 14-3-3 proteins. J Biol Chem (2004) 1.23
Positive and negative regulation of APP amyloidogenesis by sumoylation. Proc Natl Acad Sci U S A (2002) 1.20
Repression of Smad4 transcriptional activity by SUMO modification. Biochem J (2004) 1.17
Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity. Mol Cell Biol (2004) 1.14
p38 Mitogen-activated protein kinase-, calcium-calmodulin-dependent protein kinase-, and calcineurin-mediated signaling pathways transcriptionally regulate myogenin expression. Mol Biol Cell (2002) 1.13
Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23;p13). Cancer Sci (2004) 1.08
Histone modifications: Now summoning sumoylation. Proc Natl Acad Sci U S A (2003) 0.89
The HDAC complex and cytoskeleton. Novartis Found Symp (2004) 0.85
Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell (2006) 11.38
ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol Cell (2006) 5.01
HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol Cell (2007) 3.99
Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol Cell Biol (2006) 2.01
Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Mol Cell (2003) 1.95
Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes. Mol Cell Biol (2008) 1.89
YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease. Biochem Cell Biol (2009) 1.81
Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. J Biol Chem (2005) 1.58
HBO1 HAT complexes target chromatin throughout gene coding regions via multiple PHD finger interactions with histone H3 tail. Mol Cell (2009) 1.58
Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention. J Biol Chem (2004) 1.47
A histone deacetylase 4/myogenin positive feedback loop coordinates denervation-dependent gene induction and suppression. Mol Biol Cell (2008) 1.44
Comprehensive lysine acetylomes emerging from bacteria to humans. Trends Biochem Sci (2010) 1.40
Functional characterization of an amino-terminal region of HDAC4 that possesses MEF2 binding and transcriptional repressive activity. J Biol Chem (2003) 1.40
Mutations in KAT6B, encoding a histone acetyltransferase, cause Genitopatellar syndrome. Am J Hum Genet (2012) 1.39
MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2. Oncogene (2002) 1.34
Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain. Nucleic Acids Res (2002) 1.33
Caspase-mediated specific cleavage of human histone deacetylase 4. J Biol Chem (2004) 1.29
The crystal structure of the ING5 PHD finger in complex with an H3K4me3 histone peptide. Proteins (2008) 1.27
MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation. J Biol Chem (2002) 1.20
Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation. J Cell Sci (2004) 1.14
p38 Mitogen-activated protein kinase-, calcium-calmodulin-dependent protein kinase-, and calcineurin-mediated signaling pathways transcriptionally regulate myogenin expression. Mol Biol Cell (2002) 1.13
Histone deacetylases as transducers and targets of nuclear signaling. J Cell Biochem (2008) 1.11
Exchange of associated factors directs a switch in HBO1 acetyltransferase histone tail specificity. Genes Dev (2013) 1.08
The tumor suppressor kinase LKB1 activates the downstream kinases SIK2 and SIK3 to stimulate nuclear export of class IIa histone deacetylases. J Biol Chem (2013) 1.08
Phosphorylation-dependent sumoylation regulates estrogen-related receptor-alpha and -gamma transcriptional activity through a synergy control motif. Mol Endocrinol (2007) 1.07
Transforming growth factor-beta inhibits telomerase through SMAD3 and E2F transcription factors. Cell Signal (2007) 1.06
Mice lacking α-tubulin acetyltransferase 1 are viable but display α-tubulin acetylation deficiency and dentate gyrus distortion. J Biol Chem (2013) 1.06
Tandem PHD fingers of MORF/MOZ acetyltransferases display selectivity for acetylated histone H3 and are required for the association with chromatin. J Mol Biol (2012) 1.05
Conserved molecular interactions within the HBO1 acetyltransferase complexes regulate cell proliferation. Mol Cell Biol (2011) 1.03
Corepressor recruitment by agonist-bound nuclear receptors. Vitam Horm (2004) 1.02
K-acetylation and its enzymes: overview and new developments. Handb Exp Pharmacol (2011) 0.95
Dephosphorylation and caspase processing generate distinct nuclear pools of histone deacetylase 4. Mol Cell Biol (2007) 0.93
Identification of the ankyrin repeat proteins ANKRA and RFXANK as novel partners of class IIa histone deacetylases. J Biol Chem (2005) 0.90
Dietary, metabolic, and potentially environmental modulation of the lysine acetylation machinery. Int J Cell Biol (2010) 0.90
Sumoylation of Krüppel-like factor 4 inhibits pluripotency induction but promotes adipocyte differentiation. J Biol Chem (2013) 0.87
PCAF is a coactivator for p73-mediated transactivation. Oncogene (2003) 0.87
Lysine acetylation: enzymes, bromodomains and links to different diseases. Essays Biochem (2012) 0.86
Dephosphorylation at a conserved SP motif governs cAMP sensitivity and nuclear localization of class IIa histone deacetylases. J Biol Chem (2013) 0.85
Expression, purification, and analysis of MOZ and MORF histone acetyltransferases. Methods (2003) 0.85
Histone acetyltransferases and deacetylases: molecular and clinical implications to gastrointestinal carcinogenesis. Acta Biochim Biophys Sin (Shanghai) (2012) 0.84
Sequence-specific recognition of a PxLPxI/L motif by an ankyrin repeat tumbler lock. Sci Signal (2012) 0.83
A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells. Prostate (2006) 0.80
The SUMO conjugating enzyme Ubc9 is required for inducing and maintaining stem cell pluripotency. Stem Cells (2014) 0.80
Pharmacological inhibition of histone deacetylases for the treatment of cancer, neurodegenerative disorders and inflammatory diseases. Expert Opin Drug Discov (2008) 0.78
BRPF1 is essential for development of fetal hematopoietic stem cells. J Clin Invest (2016) 0.76
Reconstitution of active and stoichiometric multisubunit lysine acetyltransferase complexes in insect cells. Methods Mol Biol (2012) 0.75
Correction: The Lysine Acetyltransferase Activator Brpf1 Governs Dentate Gyrus Development through Neural Stem Cells and Progenitors. PLoS Genet (2015) 0.75
Mice lacking α-tubulin acetyltransferase 1 are viable but display α-tubulin acetylation deficiency and dentate gyrus distortion. J Biol Chem (2016) 0.75
Analysis of protein lysine acetylation in vitro and in vivo. Curr Protoc Protein Sci (2008) 0.75